Vicore
Business Services · Michigan, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2950 W Square Lake Rd Ste 103, Troy, Mic...Phone Number
(248) 687-6818Website
www.vicoretech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vicore
Vicore is an Information Technology Solution provider that delivers Secure Optimized IT Solutions to small and mid-sized companies in Michigan and across the United States. We are dedicated to helping our clients gain a competitive advantage by securing and optimizing their IT environments, and leveraging leading technologies to improve productivity and reduce technology cost. Vicore can work with you to optimize the return on your systems investments. We can help you avoid dead-end technologies by creating a cost-effective plan to migrate from existing expensive, proprietary platforms to more cost-effective and flexible client-server computing environments. Our fully certified staff is committed to the highest quality solutions in technical planning, implementation, support and consulting to insure maximum cost efficiency and long term client savings. At Vicore, we focus on building long lasting relationships with clients by providing quality, cost-effective IT solutions. We partner wRead more
Vicore Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vicore your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vicore recently announced quarterly report
Funding: Get notified immidiatlly once Vicore has new funding data
Vicore, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Vicore
Check out if Vicore is spiking on competitors!
Click to see if Vicore had a recent Job posting/layoffs
Product Launch: Get notified when Vicore launches new products
Check if Vicore has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Vicore
Find 2 more new buyers
Compare Similar Companies to Vicore
Compare insights from companies similar to Vicore, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vicore is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vicore is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vicore.
Vicore Tech Stack
A closer look at the technologies used by Vicore
Vicore News & Media
Vicore provides an update on the ATTRACT-3 COVID-19 trial
· ATTRACT-3 did not meet its primary endpoint, reduction of all-cause mortality at 60 days · Lack of effect explained by new virus mutations · No safety signals detected · The company will focus the development of C21 for the treatment of IPF and PAH Gothenburg, September 15, 2022 – Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (AT2R), today announces the top-lineVicore update on the AIR phase 2 trial in idiopathic pulmonary fibrosis
· The previously reported February interim analysis will be presented as a late breaker at the ERS congress · Observations of continued stabilization and increase in lung capacity · A second interim analysis and update on the development program are planned for Q4 2022 Gothenburg, September 2, 2022 – Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (AT2R), gives a short update and informsVicore resolves on a set-off issue of 87,686 shares as part of milestone compensation
· Milestone compensation to collaboration partners in connection with the first patient dosed with C106. · One-time payment to the company's collaboration partners Emeriti Bio and HaLaCore Pharma in a total of approximately 6 MSEK, of which 3 MSEK in cash compensation and 87,686 newly issued shares in Vicore corresponding to approximately 3 MSEK. Gothenburg, June 17, 2022 - Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiMichael Wolff Jensen resigns from the Vicore board of directors and is replaced by Jacob Gunterberg as chairman of the board up until the annual general meeting in May 2022
Gothenburg, March 23, 2022 – Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (ATRAGs), today announces that Michael Wolff Jensen has resigned from the board of directors. Michael Wolff Jensen, who has been the chairman of the board of directors of Vicore Pharma Holding AB (publ) since 2020, has today informed the board of directors of his resignation as chairman and member of the
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vicore
Sign Up For FreeTo access detailed company insights
Vicore is an Information Technology Solution provider that delivers Secure Optimized IT Solutions to small and mid-sized companies in Michigan and across the United States. We are dedicated to helping our clients gain a competitive advantage by securing and optimizing their IT environments, and leveraging leading technologies to improve productivit... Read More
